Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, Los Angeles, California.
Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, Los Angeles, California; Division of Cardiac Surgery, Department of Surgery, University of California, Los Angeles, Los Angeles, California.
Ann Thorac Surg. 2021 Nov;112(5):1639-1646. doi: 10.1016/j.athoracsur.2020.11.004. Epub 2020 Nov 27.
Frailty has been widely recognized as a predictor of postoperative outcomes. Given the paucity of standardized frailty measurements in thoracic procedures, this study aimed to determine the impact of coding-based frailty on clinical outcomes and resource use after anatomic lung resection.
All adults undergoing elective, anatomic lung resections (segmentectomy, lobectomy, pneumonectomy) from 2005 to 2014 were identified using the National Inpatient Sample. Patients were categorized as either frail or nonfrail on the basis of the presence of any frailty-defining diagnoses defined by the Johns Hopkins Adjusted Clinical Groups. Multivariable models were used to assess the independent association of frailty with in-hospital mortality, nonhome discharge, complications, duration of stay, and costs.
Of an estimated 366,357 hospitalizations for elective lung resection during the study period, 4.4% were in frail patients. Patients who underwent pneumonectomy or were treated at low-volume hospitals were more commonly frail. Relative to nonfrail patients, frailty was associated with increased unadjusted mortality (9.1% vs 1.7%; P < .001) and nonhome discharge (44.7% vs 10.5%; P < .001). Frail patients had 3.47 increased adjusted odds of mortality across resection types (95% confidence interval, 2.94 to 4.09). Frailty conferred the greatest increase in mortality, complications, and resource use after pneumonectomy relative to lobectomy or segmentectomy, although significant differences were evident for all 3 operations.
Frailty exhibits a strong association with inferior clinical outcomes and increased resource use after elective lung resection, particularly pneumonectomy. This readily available tool may improve preoperative risk assessment and allow for better selection of treatment modalities for frail patients with pulmonary disorders.
衰弱已被广泛认为是术后结果的预测指标。鉴于在胸科手术中缺乏标准化的衰弱测量方法,本研究旨在确定基于编码的衰弱对解剖性肺切除术后临床结果和资源利用的影响。
使用国家住院患者样本(National Inpatient Sample)确定了 2005 年至 2014 年间所有接受择期解剖性肺切除术(肺段切除术、肺叶切除术、全肺切除术)的成年人。根据约翰霍普金斯调整临床组(Johns Hopkins Adjusted Clinical Groups)定义的任何衰弱定义诊断,患者被归类为衰弱或非衰弱。使用多变量模型评估衰弱与院内死亡率、非家庭出院、并发症、住院时间和费用的独立关联。
在研究期间,估计有 366357 例择期肺切除手术住院患者中,有 4.4%的患者为衰弱患者。接受全肺切除术或在低容量医院接受治疗的患者更常见衰弱。与非衰弱患者相比,衰弱与未经调整的死亡率增加(9.1%对 1.7%;P<0.001)和非家庭出院(44.7%对 10.5%;P<0.001)相关。衰弱患者在所有 3 种切除术类型中死亡的校正后优势比增加了 3.47(95%置信区间,2.94 至 4.09)。与肺叶切除术或肺段切除术相比,全肺切除术患者的死亡率、并发症和资源利用率增加最多,但所有 3 种手术均存在显著差异。
衰弱与择期肺切除术后较差的临床结果和资源利用增加密切相关,尤其是全肺切除术。这种现成的工具可以改善术前风险评估,并为患有肺部疾病的衰弱患者选择更好的治疗方式。